In a Victory for Covered Entities, Fifth Circuit Upholds Louisiana’s 340B Contract Pharmacy Protection Law

2/11/2026 – In a Victory for Covered Entities, Fifth Circuit Upholds Louisiana’s 340B Contract Pharmacy Protection Law In a consolidated decision involving AbbVie, AstraZeneca, and the Pharmaceutical Research and Manufacturers of America…

HRSA Takes Steps to Pursue New 340B Rebate Model

2/11/2026 – HRSA Takes Steps to Pursue New 340B Rebate Model HRSA announced its intention to pursue a new 340B rebate model last week through submission of a “Prerule” regarding…

Trump’s Online Marketplace for Direct-to-Consumer Drugs is Now Live, and Could Impact 340B

2/10/2026 – Trump’s Online Marketplace for Direct-to-Consumer Drugs is Now Live, and Could Impact 340B Last week, HHS launched its website TrumpRx.gov which the Administration says is intended to “facilitate direct-to-consumer purchasing…

CMS Announces Drugs Subject to IRA Negotiated Prices Starting in 2028

1/30/2026 CMS Announces Drugs Subject to IRA Negotiated Prices Starting in 2028 Please click on the link below: CMS Announces Drugs Subject to IRA Negotiated Prices Starting in 2028 Powers…

Eli Lilly Announces Covered Entities Must Submit Claims Data for All of Its Products

1/16/2026 – Eli Lilly Announces Covered Entities Must Submit Claims Data for All of Its Products Pharmaceutical manufacturer Eli Lilly announced that, effective February 1, all covered entities must submit claims-level…

Response to 340B ACCESS Act Sign-on Letter

01/16/2025 – Response to 340B ACCESS Act Sign-on Letter Several patient and provider organizations sent a letter to the House Energy and Commerce committee in October 2025 supporting legislation opposed…

First Circuit Reaffirms Rebate Pilot Pause; CMS Proposes Models Requiring Drug Manufacturers to Pay Additional Rebates on Medicare Drugs if the Net Prices Under the IRA Exceed Prices in Similar Countries

1/8/2026 – First Circuit Reaffirms Rebate Pilot Pause; CMS Proposes Models Requiring Drug Manufacturers to Pay Additional Rebates on Medicare Drugs if the Net Prices Under the IRA Exceed Prices…

Rebate Pilot Litigation Update: Parties Agree to “Drop” Appeal

1/12/2025 – Rebate Pilot Litigation Update: Parties Agree to “Drop” Appeal This morning, DOJ filed a letter with the First Circuit Court of Appeals (First Circuit) stating that the government and hospital plaintiffs…

HRSA Confirms Suspension of Rebate Pilot

12/31/2025 – HRSA Confirms Suspension of Rebate Pilot Today, HRSA updated its website to confirm that its controversial 340B rebate model pilot program (rebate pilot) is suspended. HRSA states that…

District Court Halts Rebate Pilot for all Covered Entities, Appeal Pending

12/29/2025 – District Court Halts Rebate Pilot for all Covered Entities Today, Chief Judge Lance E. Walker from the U.S. District Court for the District of Maine issued an order…